Baylor College of Medicine | BCM Legacy Fund I
◆ Investment Thesis
Legacy Fund invests philanthropic capital at the earliest, most underfunded stage of biomedical innovation, with a particular focus on rare and pediatric diseases that are left undeveloped due to structural market challenges. The fund is designed to close the gap between a promising discovery and the point where downstream funders—often venture capital and industry—are ready to take the baton, catalyzing the translation of university lab innovations into therapies that reach patients in need.
◆ About Baylor College of Medicine
A venture capital fund funded by philanthropies that invests in early-stage biotech startups emerging from academic research. The fund bridges the gap between academic discoveries and later-stage venture capital investment.
◆ Sectors
◆ Stages
◆ Geography Focus
◆ Team
| Name | Title | Role | Links |
|---|---|---|---|
| Burton Hanson | Managing Partner | Senior | |
| Steve Lehmann | Managing Partner | Senior | |
| Debra McCoy | Board of Managers | Board | |
| Paul Thomas | Board of Managers | Board |
◆ FAQ
What does BCM Legacy Fund I invest in?
BCM Legacy Fund I invests in Biotech at the pre-seed and seed stages.
Which geographies does BCM Legacy Fund I focus on?
BCM Legacy Fund I focuses on United States, and is headquartered in United States.